Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
1.
Drug Des Devel Ther ; 15: 3523-3533, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34408404

RESUMO

BACKGROUND: Cancer is a leading cause of death worldwide, with breast cancer being the most common invasive cancer type in women. Several therapeutic strategies have been explored to reduce the mortality rates of breast cancer. Chemotherapy is the most commonly used systemic treatment, but associated with numerous side-effects. Development of anticancer agents with high efficacy and minimal negative effects is therefore an important focus of research. Natural materials provide an excellent source of bioactive compounds. For instance, Garcinia porrecta from the Clusiaceae family has multiple pharmacological activities, including antioxidant, anti-inflammatory, antibacterial, antiviral, anti-HIV, antidepressant, and anticancer properties. PURPOSE: The main objective of this study was to investigate the potential anticancer effects of compounds extracted from the bark of G. porrecta. MATERIALS AND METHODS: Our experiments were divided into three steps: (1) chromatographic isolation of compounds using various separation techniques, such as extraction, separation and purification, (2) characterization via infrared (IR), nuclear magnetic resonance (NMR) and mass spectroscopy, and (3) evaluation of anticancer activity in vitro (MTT assay) and in silico (via analysis of molecular docking against caspase-9, tumor necrosis factor alpha (TNF-α), estrogen receptor alpha (ER-α), and human epidermal growth factor receptor 2 (HER-2)). RESULTS: Depsidone (1) and benzophenone (2) from the ethyl acetate extract of bark of G. porrecta were identified as bioactive components. Examination of the activities of these compounds against MCF-7 cells revealed an IC50 value of 119.3 µg/mL for benzophenone, whereas IC50 for depsidone could not be estimated. Benzophenone activity was lower than that of the positive control doxorubicin (6.9 µg/mL). Depsidone showed the highest binding affinity for HER-2 (-9.2 kcal.mol-1) and benzophenone for ER-α (-8.0 kcal.mol-1). CONCLUSION: Benzophenone displays potency as an anticancer agent through blocking ER-α.


Assuntos
Neoplasias da Mama/tratamento farmacológico , Garcinia/química , Fenóis/farmacologia , Extratos Vegetais/farmacologia , Antineoplásicos Fitogênicos/química , Antineoplásicos Fitogênicos/isolamento & purificação , Antineoplásicos Fitogênicos/farmacologia , Benzofenonas/administração & dosagem , Benzofenonas/isolamento & purificação , Benzofenonas/farmacologia , Depsídeos/administração & dosagem , Depsídeos/isolamento & purificação , Depsídeos/farmacologia , Doxorrubicina/farmacologia , Receptor alfa de Estrogênio/antagonistas & inibidores , Feminino , Humanos , Concentração Inibidora 50 , Lactonas/administração & dosagem , Lactonas/isolamento & purificação , Lactonas/farmacologia , Células MCF-7 , Simulação de Acoplamento Molecular , Fenóis/química , Fenóis/isolamento & purificação , Extratos Vegetais/química
2.
Food Funct ; 11(9): 8297-8308, 2020 Sep 23.
Artigo em Inglês | MEDLINE | ID: mdl-32909594

RESUMO

Benzophenone glycosides are a major type of polyphenols present in guava. To date, there is still poor understanding of the relationship between benzophenone glycosides and the hepatoprotective effects attributed to this edible fruit. Herein, the protective effects of guavinoside B (GUB), a main benzophenone glycoside present in guava fruit, against acetaminophen (APAP)-induced liver injury were investigated in vitro and in vivo. Fluorescence measurement demonstrated that GUB (at a concentration of 30 µM) significantly reduced the intracellular ROS levels in APAP-treated HepG2 cells. In addition, GUB (100 mg kg-1 d-1) pretreatment markedly alleviated APAP-induced hepatocyte infiltration and necrosis in C57BL/6 mice, and improved serum and hepatic biochemical parameters, such as ALT, AST, SOD, GSH, ROS, MDA, and TNF-α levels. RT-PCR and western blot experiments revealed that GUB up-regulated Nrf2, GCLC and NQO1, while reducing p-JNK gene expression in the liver. The fermentation experiment further revealed that the displayed beneficial effects of GUB in vivo might be related to the gut microbial metabolite gallic acid. These promising data suggested that GUB showed potent hepatoprotective effects through regulating the Nrf2 and JNK signaling pathways. Further investigation of the absorption and metabolism of benzophenones would be warranted to promote the utilization of these phenolics as functional food ingredients against oxidative stress-induced chronic diseases.


Assuntos
Benzofenonas/administração & dosagem , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , MAP Quinase Quinase 4/metabolismo , Fator 2 Relacionado a NF-E2/metabolismo , Extratos Vegetais/administração & dosagem , Psidium/química , Acetaminofen/efeitos adversos , Animais , Doença Hepática Induzida por Substâncias e Drogas/genética , Doença Hepática Induzida por Substâncias e Drogas/metabolismo , Frutas/química , Hepatócitos/efeitos dos fármacos , Hepatócitos/metabolismo , Humanos , MAP Quinase Quinase 4/genética , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Fator 2 Relacionado a NF-E2/genética , Estresse Oxidativo/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacos
3.
Theranostics ; 10(19): 8541-8557, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32754262

RESUMO

Rationale: Endophthalmitis, which is one of the severest complications of cataract surgeries, can seriously threaten vision and even lead to irreversible blindness owing to its complicated microenvironment, including both local bacterial infection and severe inflammation. It is urgent to develop a comprehensive treatment for both anti-bacterial and anti-inflammatory effects. Methods: Herein, we developed AuAgCu2O-bromfenac sodium nanoparticles (AuAgCu2O-BS NPs), which was designed to combine anti-bacterial and anti-inflammatory effects for integrated therapy of endophthalmitis after cataract surgery. The AuAgCu2O-BS NPs could eradicate methicillin-resistant Staphylococcus aureus (MRSA) bacterial strain relied on their photodynamic effects and the release of metal ions (Ag+ and Cu+) by the hollow AuAgCu2O nanostructures mediated mild photothermal effects. The anti-inflammatory drug, bromfenac sodium, released from the nanoparticles were able to significantly reduce the local inflammation of the endophthalmitis and promote tissue rehabilitation. In vivo bacterial elimination and anti-inflammation were confirmed by a postcataract endophthalmitis rabbit model. Results: Excellent antibacterial ability of AuAgCu2O-BS NPs was verified both in vitro and in vivo. Ophthalmological clinical observation and pathologic histology analysis showed prominent treatment of inflammatory reaction. Importantly, the mild temperature photothermal effect not only promoted the release of metal ions and bromfenac sodium but also avoided the thermal damage of the surrounding tissues, which was more suitable for the practical application of ophthalmology due to the complex structure of the eyeball. Moreover, superior biocompatibility was approved by the preliminary toxicity investigations, including low cytotoxicity, negligible damage to major organs, and stable intraocular pressure. Conclusions: Our studies of nanosystem provide a promising synergic therapeutic strategy for postcataract endophthalmitis treatment with favorable prognosis and promise in clinical translations.


Assuntos
Antibacterianos/administração & dosagem , Anti-Inflamatórios/administração & dosagem , Benzofenonas/administração & dosagem , Bromobenzenos/administração & dosagem , Extração de Catarata/efeitos adversos , Cobre/administração & dosagem , Endoftalmite/terapia , Ouro/administração & dosagem , Staphylococcus aureus Resistente à Meticilina/efeitos dos fármacos , Prata/administração & dosagem , Animais , Antibacterianos/química , Antibacterianos/farmacologia , Anti-Inflamatórios/química , Anti-Inflamatórios/farmacologia , Benzofenonas/química , Benzofenonas/farmacologia , Bromobenzenos/química , Bromobenzenos/farmacologia , Cobre/química , Cobre/farmacologia , Modelos Animais de Doenças , Sinergismo Farmacológico , Tratamento Farmacológico , Endoftalmite/etiologia , Endoftalmite/microbiologia , Ouro/química , Ouro/farmacologia , Humanos , Nanopartículas Metálicas , Staphylococcus aureus Resistente à Meticilina/crescimento & desenvolvimento , Viabilidade Microbiana/efeitos dos fármacos , Terapia Fototérmica , Coelhos , Prata/química , Prata/farmacologia , Resultado do Tratamento
4.
Neurotox Res ; 37(3): 683-701, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-31970650

RESUMO

Benzophenone-3 (BP-3), the most widely used UV chemical filter, is absorbed well through the skin and gastrointestinal tract and can affect some body functions, including the survival of nerve cells. Previously, we showed that BP-3 evoked a neurotoxic effect in male rats, but since the effects of this compound are known to depend on gender, the aim of the present study was to show the concentration and potential neurotoxic action of this compound in the female rat brain. BP-3 was administered dermally to female rats during pregnancy, and then in the 7th and 8th weeks of age to their female offspring. The effect of BP-3 exposure on short-term and spatial memory, its concentrations in blood, the liver, the frontal cortex, and the hippocampus, and the effect on selected markers of brain damage were determined. Also, the impact of BP-3 on sex and thyroid hormone levels in blood and hematological parameters was examined. It has been found that this compound was present in blood and brain structures in females at a lower concentration than in males. BP-3 in both examined brain structures increased extracellular glutamate concentration and enhanced lipid peroxidation, but did not induce the apoptotic process. The tested compound also evoked hyperthyroidism and decreased the blood progesterone level and the number of erythrocytes. The presented data indicated that, after the same exposure to BP-3, this compound was at a lower concentration in the female brain than in that of the males. Although BP-3 did not induce apoptosis in the hippocampus and frontal cortex, the increased extracellular glutamate concentration and lipid peroxidation, as well as impaired spatial memory, suggested that this compound also had adverse effects in the female brain yet was weaker than in males. In contrast to the weaker effects of the BP-3 on females than the brain of males, this compound affected the endocrine system and evoked a disturbance in hematological parameters more strongly than in male rats.


Assuntos
Apoptose/efeitos dos fármacos , Benzofenonas/toxicidade , Lobo Frontal/efeitos dos fármacos , Hormônios Esteroides Gonadais/sangue , Hipocampo/efeitos dos fármacos , Protetores Solares/toxicidade , Hormônios Tireóideos/sangue , Administração Cutânea , Animais , Proteínas Reguladoras de Apoptose/efeitos dos fármacos , Benzofenonas/administração & dosagem , Feminino , Lobo Frontal/metabolismo , Ácido Glutâmico/metabolismo , Hipocampo/metabolismo , Ratos Sprague-Dawley , Receptores de Hidrocarboneto Arílico/metabolismo , Receptores de Estrogênio/metabolismo , Receptores de Progesterona/metabolismo , Protetores Solares/administração & dosagem
5.
J Vasc Interv Radiol ; 29(8): 1078-1084, 2018 08.
Artigo em Inglês | MEDLINE | ID: mdl-29910164

RESUMO

PURPOSE: To assess feasibility and efficacy of CKD-516, a vascular disrupting agent, in transarterial chemoembolization in a liver tumor model. MATERIALS AND METHODS: A VX2 carcinoma strain was implanted in rabbit liver (n = 40) and incubated for 2 weeks. After confirmation of tumor growth using computed tomography, transarterial chemoembolization was performed. CKD-516 was dissolved in ethiodized oil, and animals were allocated to 4 treatment groups (n = 10 in each): group A, ethiodized oil; group B, ethiodized oil/CKD-516; group C, ethiodized oil + doxorubicin; group D, ethiodized oil/CKD-516 + doxorubicin. To assess hepatic damage, serum aspartate transaminase and alanine transaminase levels were measured on day 1, 3, and 7 after delivery. To assess tumor necrosis, animals were euthanized on day 7, and explanted tumors were stained with hematoxylin and eosin and a terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling assay. Percentage areas of viable tumors were calculated using digitalized histopathologic specimen images. RESULTS: Tumor viability rates were 47.1% ± 11.4%, 27.5% ± 13.6%, 14.4% ± 12.5%, and 0.7% ± 1.0% in groups A, B, C, and D (P < .001). Liver enzyme levels were elevated after drug delivery but recovered during follow-up. Significant between-group differences were observed on days 1, 3, and 7 (aspartate transaminase and alanine transaminase: P = .0135 and P = .0134, P = .0390 and P = .0084, and P = .8260 and P = .0440). CONCLUSIONS: Treatment with a combination of CKD-516 and conventional transarterial chemoembolization showed therapeutic benefit in a liver tumor model.


Assuntos
Inibidores da Angiogênese/administração & dosagem , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Benzofenonas/administração & dosagem , Quimioembolização Terapêutica/métodos , Doxorrubicina/administração & dosagem , Óleo Etiodado/administração & dosagem , Neoplasias Hepáticas Experimentais/irrigação sanguínea , Neoplasias Hepáticas Experimentais/terapia , Valina/análogos & derivados , Alanina Transaminase/sangue , Inibidores da Angiogênese/toxicidade , Animais , Protocolos de Quimioterapia Combinada Antineoplásica/toxicidade , Aspartato Aminotransferases/sangue , Benzofenonas/toxicidade , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Quimioembolização Terapêutica/efeitos adversos , Doxorrubicina/toxicidade , Óleo Etiodado/toxicidade , Neoplasias Hepáticas Experimentais/diagnóstico por imagem , Neoplasias Hepáticas Experimentais/patologia , Masculino , Necrose , Coelhos , Fatores de Tempo , Tomografia Computadorizada por Raios X , Carga Tumoral/efeitos dos fármacos , Valina/administração & dosagem , Valina/toxicidade
6.
Molecules ; 20(3): 4410-29, 2015 Mar 09.
Artigo em Inglês | MEDLINE | ID: mdl-25759957

RESUMO

In vitro and in vivo studies of the activity of Phaleria macrocarpa Boerl (Thymelaeaceae) leaves against the therapeutic target for hypercholesterolemia were done using the HDL receptor (SR-BI) and hypercholesterolemia-induced Sprague Dawley rats. The in vitro study showed that the active fraction (CF6) obtained from the ethyl acetate extract (EMD) and its component 2',6',4-trihydroxy-4'-methoxybenzophenone increased the SR-BI expression by 95% and 60%, respectively. The in vivo study has proven the effect of EMD at 0.5 g/kgbw dosage in reducing the total cholesterol level by 224.9% and increasing the HDL cholesterol level by 157% compared to the cholesterol group. In the toxicity study, serum glutamate oxalate transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) activity were observed to be at normal levels. The liver histology also proved no toxicity and abnormalities in any of the treatment groups, so it can be categorized as non-toxic to the rat liver. The findings taken together show that P. macrocarpa leaves are safe and suitable as an alternative control and prevention treatment for hypercholesterolemia in Sprague Dawley rats.


Assuntos
Anticolesterolemiantes/administração & dosagem , Colesterol/metabolismo , Hipercolesterolemia/tratamento farmacológico , Lipoproteínas HDL/metabolismo , Extratos Vegetais/administração & dosagem , Extratos Vegetais/química , Receptores de Lipoproteínas/metabolismo , Thymelaeaceae/química , Animais , Anticolesterolemiantes/química , Anticolesterolemiantes/farmacologia , Benzofenonas/administração & dosagem , Benzofenonas/química , Benzofenonas/farmacologia , Dieta Hiperlipídica/efeitos adversos , Células Hep G2 , Humanos , Hipercolesterolemia/induzido quimicamente , Hipercolesterolemia/metabolismo , Fígado/efeitos dos fármacos , Masculino , Extratos Vegetais/farmacologia , Folhas de Planta/química , Ratos , Ratos Sprague-Dawley
7.
Anticancer Res ; 34(4): 1715-22, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24692701

RESUMO

AIM: To evaluate the anticancer efficacy of CKD-516, a novel vascular-disrupting agent, alone and in combination with doxorubicin in the treatment of hepatocellular carcinoma (HCC). MATERIALS AND METHODS: In mice bearing luciferized HCC cells, therapeutic efficacy was assessed for seven days after single administration of CKD-516, doxorubicin, or combination of CKD-516 and doxorubicin. RESULTS: Bioluminescence-imaging (BLI) signals in the CKD-516 group abruptly decreased initially, but recovered at seven days after treatment. BLI signals in the doxorubicin group gradually decreased over the 7-day period. In the combination group, BLI signals were abruptly reduced and remained suppressed for the 7-day period. On histopathological examination, CKD-516-treated tumors showed extensive central necrosis, whereas the peripheral layers remained viable. Doxorubicin-treated tumors showed mild and scattered necrosis. Tumors from the combination group showed more extensive central and peripheral necrosis, with smaller viable peripheral layers than the CKD-516 group. CONCLUSION: Combination therapy can have additive effects for treatment of HCC compared with CKD-516 or doxorubicin monotherapy.


Assuntos
Benzofenonas/farmacologia , Carcinoma Hepatocelular/patologia , Doxorrubicina/farmacologia , Neoplasias Hepáticas/patologia , Valina/análogos & derivados , Animais , Apoptose/efeitos dos fármacos , Benzofenonas/administração & dosagem , Carcinoma Hepatocelular/tratamento farmacológico , Linhagem Celular Tumoral , Modelos Animais de Doenças , Doxorrubicina/administração & dosagem , Avaliação Pré-Clínica de Medicamentos , Sinergismo Farmacológico , Humanos , Neoplasias Hepáticas/tratamento farmacológico , Camundongos , Necrose , Neovascularização Patológica/tratamento farmacológico , Carga Tumoral/efeitos dos fármacos , Valina/administração & dosagem , Valina/farmacologia , Ensaios Antitumorais Modelo de Xenoenxerto
8.
Naunyn Schmiedebergs Arch Pharmacol ; 385(11): 1103-9, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22926730

RESUMO

This study was undertaken to evaluate the gastroprotective properties of seed, leaf, and branch methanolic extracts and guttiferone A obtained from Garcinia achachairu (Clusiaceae). Mice were used in all the models, and treatments were administered orally only in pylorus-ligated model of the extracts, and drugs were administered intraduodenally. Treatment with different extracts (500 mg/kg) significantly reduced the ulcerative lesions in the ethanol/HCl-induced model; however, the seed extract was most active. When tested in different doses (50, 250, or 500 mg/kg), the seed extract of G. achaicharu showed a dose-dependent effect with a percentage of inhibition of gastric lesions of 41, 49, and 85 %, respectively. The seed extract also significantly reduced the ulcerative lesions in the indomethacin/bethanechol-induced ulcer. In this model, the percentage of inhibition of ulcer was 24, 58, and 90 %, respectively. Regarding the model of gastric secretion, a reduction of gastric juice volume and total acidity was observed, as well as an increase in gastric pH. Considering that the seed extract was the most active, it was subjected to silica gel column chromatography, leading to the isolation of guttiferone A. The isolated compound and omeprazole were evaluated in the HCl/ethanol-induced ulcer model. In this assay, both compounds at a dose of 30 mg/kg reduced the ulcerative lesions by about 75 %. These results demonstrate, for the first time, that extracts obtained from G. achachairu and guttiferone A produce gastroprotective effects, corroborating ethnomedicinal use of this plant.


Assuntos
Antiulcerosos/farmacologia , Benzofenonas/farmacologia , Garcinia/química , Extratos Vegetais/farmacologia , Animais , Antiulcerosos/administração & dosagem , Antiulcerosos/isolamento & purificação , Benzofenonas/administração & dosagem , Benzofenonas/isolamento & purificação , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Úlcera Duodenal/patologia , Úlcera Duodenal/prevenção & controle , Concentração de Íons de Hidrogênio , Masculino , Camundongos , Omeprazol/farmacologia , Extratos Vegetais/administração & dosagem , Folhas de Planta , Sementes , Úlcera Gástrica/patologia , Úlcera Gástrica/prevenção & controle
9.
Planta Med ; 73(7): 644-9, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17562491

RESUMO

Prior studies have emphasized the anti-inflammatory and antioxidant properties of polyisoprenylated benzophenone derivatives, but their putative effect on allergic conditions has not yet been addressed. In the current study, the naturally occurring 7-epiclusianone, isolated from Garcinia brasiliensis, was investigated to check its effectiveness on allergen-evoked intestinal spasm. The standard antiallergic azelastine was used for comparison. We found that 7-epiclusianone and azelastine inhibited antigen-induced contractions of guinea pig ileum with similar IC (50) values (2.3 +/- 1.1 microM and 3.3 +/- 1.2 microM, respectively). A similar blockade of anaphylactic histamine release from the ileum was also noted. In contrast, azelastine was more potent than 7-epiclusianone to prevent spasms induced by histamine (IC (50) = 6.3 +/- 0.2 nM and 3.7 +/- 0.1 microM, respectively). These findings reveal that 7-epiclusianone is clearly active against the anaphylactic response and should be considered as a molecular template in drug discovery for allergic syndromes.


Assuntos
Antialérgicos/farmacologia , Benzofenonas/farmacologia , Benzoquinonas/farmacologia , Garcinia , Íleo/efeitos dos fármacos , Contração Muscular/efeitos dos fármacos , Fitoterapia , Traqueia/efeitos dos fármacos , Alérgenos , Animais , Antialérgicos/administração & dosagem , Antialérgicos/uso terapêutico , Benzofenonas/administração & dosagem , Benzofenonas/uso terapêutico , Benzoquinonas/administração & dosagem , Benzoquinonas/uso terapêutico , Relação Dose-Resposta a Droga , Feminino , Frutas , Cobaias , Concentração Inibidora 50 , Masculino , Ftalazinas/farmacologia , Extratos Vegetais/administração & dosagem , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico
10.
Br J Dermatol ; 152(6): 1263-7, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15948991

RESUMO

BACKGROUND: Insect repellents and sunscreens are over-the-counter products extensively used by the general public. Concurrent application of these products has become widespread in many regions across North America, because of concerns about West Nile virus and skin cancers. OBJECTIVES: We investigated whether formulation type, application amount, and sequence would affect the percutaneous absorption profiles of the active repellent and sunscreen ingredients. METHODS: In vitro percutaneous permeation of the repellent N,N-diethyl-m-toluamide (DEET) and the sunscreen oxybenzone from concurrent application of five commercially available products (A, repellent spray; B, repellent lotion; C, sunscreen lotion; D and E, combined repellent/sunscreen lotions) was measured and compared using Franz-style diffusion cells with piglet skin at 37 degrees C. RESULTS: Penetration of DEET in A and B increased by 1640% and 282%, respectively, when C was applied concurrently. Penetration of DEET in D and E was 53% and 79% higher than that in B. Permeation of DEET from A + C (2:1) and A + C (1: 2) increased by 530% and 278%, respectively. Permeation of oxybenzone was 189% and 280% higher in A + C and B + C than in C. Permeation of oxybenzone in D and E was also 221% and 296% higher than that in C. Permeation of oxybenzone was 196% greater when A was applied on top of C than when C was applied on top of A, while oxybenzone in A + C (1:2) permeated 171% more than that in A + C (2:1). CONCLUSIONS: Concurrent application of commercially available repellent and sunscreen products resulted in significant synergistic percutaneous permeation of the repellent DEET and the sunscreen oxybenzone in vitro. The percutaneous penetration profiles were dependent upon the type of formulation, application sequence and application proportion.


Assuntos
Benzofenonas/administração & dosagem , DEET/administração & dosagem , Repelentes de Insetos/administração & dosagem , Medicamentos sem Prescrição , Absorção Cutânea/efeitos dos fármacos , Protetores Solares/administração & dosagem , Administração Tópica , Animais , Benzofenonas/farmacocinética , Cromatografia Líquida de Alta Pressão , DEET/farmacocinética , Esquema de Medicação , Avaliação Pré-Clínica de Medicamentos , Sinergismo Farmacológico , Repelentes de Insetos/farmacocinética , Modelos Animais , Protetores Solares/farmacocinética , Suínos
11.
Fitoterapia ; 75(7-8): 683-9, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15567244
12.
Planta Med ; 69(9): 864-6, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-14598218

RESUMO

Bioassay-guided fractionation of the EtOAc extract of the twigs of Garcinia macrophylla from Suriname produced the known benzophenone, guttiferone A (1), and a new guttiferone analogue, guttiferone G (2). Friedelin was also isolated. The structures of compounds 1 and 2 were elucidated using 1D and 2D NMR spectroscopy. Compounds 1 and 2 were weakly cytotoxic in the A2780 human ovarian cell line, with IC (50) values of 6.8 and 8.0 microg/mL, respectively.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Benzofenonas/farmacologia , Garcinia , Fitoterapia , Extratos Vegetais/farmacologia , Antineoplásicos Fitogênicos/administração & dosagem , Antineoplásicos Fitogênicos/química , Antineoplásicos Fitogênicos/uso terapêutico , Benzofenonas/administração & dosagem , Benzofenonas/química , Benzofenonas/uso terapêutico , Linhagem Celular Tumoral/efeitos dos fármacos , Relação Dose-Resposta a Droga , Feminino , Humanos , Concentração Inibidora 50 , Espectroscopia de Ressonância Magnética , Neoplasias Ovarianas/prevenção & controle , Extratos Vegetais/administração & dosagem , Extratos Vegetais/química , Extratos Vegetais/uso terapêutico , Suriname
13.
Planta Med ; 69(12): 1141-6, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14750032

RESUMO

Three new protostanes, garciosaterpenes A ( 1), B ( 2) and C ( 3), together with a new digeranylbenzophenone, garciosaphenone A ( 4) were isolated from the ethyl acetate fractions obtained from the crude methanol extracts of the trunk bark and stems of Garcinia speciosa. The structures were elucidated by spectroscopic methods and chemical reactions. Compounds 1 and 3 showed significant inhibitory activities (IC (50) 15.5 and 12.2 microg/mL, respectively) against HIV-1 reverse transcriptase and in the syncytium assay (EC (50) 5.8 microg/mL with TI 3.4 and 37.0 microg/mL with TI 1.9, respectively). Compound 4 was active in HIV-1 RT assay (IC (50) 23.9 microg/mL), but toxic in the syncytium assay. This work represents the first report on the anti-HIV-1 activities of the protostane triterpenes.


Assuntos
Fármacos Anti-HIV/farmacologia , Garcinia , Transcriptase Reversa do HIV/efeitos dos fármacos , Fitoterapia , Extratos Vegetais/farmacologia , Inibidores da Transcriptase Reversa/farmacologia , Fármacos Anti-HIV/administração & dosagem , Fármacos Anti-HIV/uso terapêutico , Benzofenonas/administração & dosagem , Benzofenonas/farmacologia , Benzofenonas/uso terapêutico , Humanos , Concentração Inibidora 50 , Casca de Planta , Extratos Vegetais/administração & dosagem , Extratos Vegetais/uso terapêutico , Caules de Planta , Inibidores da Transcriptase Reversa/administração & dosagem , Inibidores da Transcriptase Reversa/uso terapêutico , Triterpenos/administração & dosagem , Triterpenos/farmacologia , Triterpenos/uso terapêutico
14.
Pharm Res ; 15(12): 1863-8, 1998 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9892470

RESUMO

PURPOSE: To study epidermal and polyethylene membrane penetration and retention of the sunscreen benzophenone-3 (BP) from a range of single solvent vehicles and evaluate solvent effects on permeability parameters. METHODS: The solubility of BP was measured in a number of solvents. Penetration of BP across human epidermis and high density polyethylene (HDPE) membranes was studied from 50% saturated solutions in each solvent. RESULTS: Maximal BP fluxes from the solvents across the two membranes varied widely. Highest fluxes were observed from 90% ethanol (EtOH) for epidermis and from isopropyl myristate (IPM) and C12-15 benzoate alcohols (C12-15 BA) for HDPE membrane. Both the flux and estimated permeability coefficient and skin-vehicle partitioning of BP appeared to be related to the vehicle solubility parameter (delta(v)). The major effects of solvents on BP flux appear to be via changes in BP diffusivity through the membranes. CONCLUSIONS: Minimal penetration of sunscreens such as BP is best achieved by choosing vehicles with a delta(v) substantially different to the solubility parameter of the membrane.


Assuntos
Benzofenonas/farmacocinética , Epiderme/metabolismo , Membranas Artificiais , Polietilenos , Protetores Solares/farmacocinética , Administração Tópica , Benzofenonas/administração & dosagem , Óleo de Coco , Difusão , Composição de Medicamentos , Epiderme/efeitos dos fármacos , Etanol/farmacologia , Feminino , Humanos , Técnicas In Vitro , Óleos de Plantas/farmacologia , Solubilidade , Solventes/farmacologia , Protetores Solares/administração & dosagem , Termodinâmica
15.
Agents Actions ; 25(1-2): 77-85, 1988 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-3189047

RESUMO

Bromfenac [2-amino-3-(4-bromobenzoyl)benzeneacetic acid sodium salt sesquihydrate] is an anti-inflammatory/analgesic agent that possesses potent topical activity in rats, guinea pigs, and mice. In rat models of acute (carrageenan paw edema) and chronic (adjuvant arthritis) inflammation, preparations of bromfenac at concentrations as low as 0.01-0.32% (0.01-0.32 mg bromfenac) produced significant anti-inflammatory activity when applied to the injected paw or to the backs of rats. In the acute paw edema test, topical bromfenac was more potent than indomethacin or hydrocortisone and about as active as triamcinolone acetonide. Bromfenac, at concentrations of 0.1-0.32%, showed topical analgesic activity in the acetylcholine-induced abdominal constriction test in mice. In this test, bromfenac was more potent than indomethacin (24.9X), more potent than ketoprofen (approximately 14.9X), and superior to piroxicam. In the guinea pig UV-erythema test, bromfenac was active (26.1X indomethacin) when applied to the UV-exposed site, but not when applied away from the site. The results suggest that bromfenac has activity topically because of a local and a systemic effect. Test results obtained with a long (4-7 hr) pretreatment time (paw edema, adjuvant arthritis, abdominal constriction) are due in great part to a systemic effect of topically applied bromfenac, while the UV-erythema test (1-hr treatment time) clearly indicates a local effect.


Assuntos
Analgésicos , Anti-Inflamatórios não Esteroides , Benzofenonas/farmacologia , Bromobenzenos/farmacologia , Administração Tópica , Animais , Artrite Experimental/tratamento farmacológico , Benzofenonas/administração & dosagem , Bromobenzenos/administração & dosagem , Avaliação Pré-Clínica de Medicamentos , Edema/tratamento farmacológico , Eritema/tratamento farmacológico , Feminino , Cobaias , Masculino , Camundongos , Camundongos Endogâmicos ICR , Dor/tratamento farmacológico , Ratos , Ratos Endogâmicos
16.
J Am Acad Dermatol ; 9(3): 354-60, 1983 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-6605370

RESUMO

A PABA ester-oxybenzone preparation is superior to PABA or sulisobenzone alone in protecting the skin from methoxsalen-induced ultraviolet A (UVA) phototoxicity after water substantivity challenge. Such a mixture would be useful as a UVA screen for uninvolved or actinically damaged skin in patients receiving psoralens and ultraviolet A (PUVA) therapy. An effective topical UVA screen also may protect against UVA-induced diseases like solar urticaria, polymorphic light eruptions, drug-induced phototoxicity or photoallergy, and possibly against the deep degenerative changes of solar elastosis.


Assuntos
Terapia PUVA/efeitos adversos , Fotoquimioterapia/efeitos adversos , Protetores Solares/administração & dosagem , Raios Ultravioleta/efeitos adversos , Ácido 4-Aminobenzoico/administração & dosagem , Adulto , Benzofenonas/administração & dosagem , Relação Dose-Resposta à Radiação , Humanos , Masculino , Queimadura Solar/prevenção & controle , para-Aminobenzoatos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA